Biochips Market Forecast to Develop, Demand and Opportunity by 2025 | Thermo Fisher Scientific, Inc., Illumina, Inc., PerkinElmer Inc., Agilent Technologies, Inc., Fluidigm Corporation, General Electric Company, Bio-Rad Laboratories Inc.

The Biochips Market research report provided by Crystal Market Research (CMR) is the most detailed study about Biochips that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.

Biochips Market Opportunities:
With high prevalence of cancer and other chronic diseases worldwide, the need for advanced drug development alternatives is increasing significantly in all parts of the world. Emerging markets such as Asia-Pacific are expected to offer significant growth opportunities for the global biochips market in coming years as expenditure on advanced research is rising considerably in developing countries such as China and India.

Major Eminent Players:
Some of the key players in Biochips Market are Thermo Fisher Scientific, Inc., Illumina, Inc., PerkinElmer Inc., Agilent Technologies, Inc., Fluidigm Corporation, General Electric Company, Bio-Rad Laboratories Inc., bioMérieux SA, and Cellix Ltd.

For more information, click on the below link @ https://www.crystalmarketresearch.com/report/biochips-market .

Biochips Market Segmentation:

By Product:
DNA Chips
Protein Chips
Lab-on-a-chip
Tissue Arrays
Cell Arrays

By Application:
Gene Expression
Genomics
SNP Genotyping
Drug Discovery & Development
Clinical Diagnostics
Cancer Diagnosis & Treatment
Proteomics
Agricultural Biotechnology
IVD and POC
High-Throughput Screening

By Fabrication Technology:
Microfluidics
Microarrays

By End User:
Academic & Research Institutes
Hospitals and Diagnostics Centers
Biotechnology and Pharmaceutical Companies

Industry Trend Analysis:
The Biochips Market is expected to be around $26 billion by 2025. Increasing advancements in personalized medicine, rising demand for miniaturization of clinical and biological test systems, increase in research activities related to proteomics and genomics, advancements in designing protein arrays and rising applications of biochips in accelerated drug development are some of the major factors driving the growth of global biochips market. Moreover, increase in the incidence of chronic diseases such as cancer has prompted development of biochips to be used for diagnosing certain variants of these diseases and for controlling disease progression. According to the National Cancer Institute under the U.S. Department of Health and Human Services, between 2012 and 2030, new cancer cases around the world are expected to increase by 50% from 14 million to 21 million. With such high incidence of cancer, the related research efforts are expected to significantly increase thus favorably contributing to the growth of biochips market during the forecast period. However, factors such as high cost of biochip instrumentation and unclear regulatory guidelines can hamper the growth of this biochips market during the forecast period.

Click Sample Copy of the Report here @ https://www.crystalmarketresearch.com/report-sample/SE09229 .

Table of Contents:
1.Introduction
2.Executive Summary
3.Market Overview
…
5.Biochips Market, By Product
5.1.Introduction
5.2.Global Biochips Sales, Revenue and Market Share by Product (2014-2018)
5.3.DNA Chips
5.4.Protein Chips
5.5.Lab-on-a-chip
5.6.Tissue Arrays
5.7.Cell Arrays
6.Biochips Market, By Application
6.1.Introduction
6.2.Global Biochips Sales, Revenue and Market Share by Application (2014-2018)
6.3.Drug Discovery & Development
6.4.Clinical Diagnostics
6.5.Gene Expression
6.6.Genomics
6.7.SNP Genotyping
6.8.Cancer Diagnosis & Treatment
6.9.Proteomics
6.10.Agricultural Biotechnology
6.11.IVD and POC
6.12.High-Throughput Screening
7.Biochips Market, By Fabrication Technology
7.1.Introduction
7.2.Global Biochips Sales, Revenue and Market Share by Fabrication Technology (2014-2018)
7.3.Microfluidics
7.4.Microarrays
To be continued...

Regional Outlook:
North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia and Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

Application Outlook and Trend Analysis:
Drug discovery and development segment held a major share of the biochips market in 2016 as biochips are being increasingly adopted for developing highly specific drug molecules and new chemical entity (NCE) drugs for the treatment of various diseases. Biochips can considerably reduce the cost of drug discovery and aid in improving drug safety and hence are being widely adopted by biotechnology and pharmaceutical companies for drug discovery applications.

To avail discount, please click on the link @ https://www.crystalmarketresearch.com/check-discount/SE09229 .

About Crystal Market Research:
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com

This release was published on openPR.